Document:

Exhibit 4.4

 

DESCRIPTION
OF THE REGISTRANT’S SECURITIES

REGISTERED
PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF 1934

 

The
following is a brief description of the common stock, $0.00001 par value per share (the “Common Stock”), of Marrone Bio Innovations,
Inc. (the “Company”), which is the only security of the Company registered pursuant to Section 12 of the Securities Exchange
Act of 1934, as amended.

 

Description
of Common Stock

 

General

 

The
following summary of the material features of our Common Stock and certain provisions of Delaware law do not purport to be complete and
is subject to, and qualified in its entirety by, the provisions of our Fourth Amended and Restated Certificate of Incorporation, our
Fifth Amended and Restated Bylaws, the Delaware General Corporation Law (“DGCL”) and other applicable law. Copies of our
Fourth Amended and Restated Certificate of Incorporation and our Fifth Amended and Restated Bylaws have been filed with the Securities
and Exchange Commission (the “SEC”) as Exhibit 3.1 and Exhibit 3.2, respectively, to our Annual Report on Form 10-K. All
of our outstanding Common Stock are validly issued, fully paid and non-assessable. Our Common Stock is listed on the Nasdaq Capital Market
and trades under the symbol “MBII.”

 

Common
Stock

 

Dividend
rights

 

Subject
to preferences that may apply to any shares of preferred stock outstanding at the time, the holders of Common Stock will be entitled
to share equally, identically and ratably in any dividends that the board of directors may determine to issue from time to time out of
legally available funds. We have never paid cash dividends on our Common Stock and do not anticipate paying periodic cash dividends on
our Common Stock for the foreseeable future.

 

Voting
rights

 

Each
holder of our Common Stock is entitled to one vote for each share on all matters submitted to a vote of the stockholders. Subject to
any rights that may be applicable to any then outstanding preferred stock, our Common Stock votes as a single class on all matters relating
to the election and removal of directors on our board of directors and as provided by law. Holders of our Common Stock do not have cumulative
voting rights. Except in respect of matters relating to the election and removal of directors on our board of directors and as otherwise
provided in our Fourth Amended and Restated Certificate of Incorporation or required by law, all matters to be voted on by our stockholders
must be approved by a majority of the shares present in person or by proxy at the meeting and entitled to vote on the subject matter.
In the case of election of directors, all matters to be voted on by our stockholders must be approved by a plurality of the votes entitled
to be cast by all shares of our Common Stock.

 

Liquidation
Rights

 

In
the event of any voluntary or involuntary liquidation, dissolution or winding up of our affairs, holders of our Common Stock would be
entitled to share ratably in our assets that are legally available for distribution to stockholders after payment of our debts and other
liabilities. If we have any preferred stock outstanding at such time, holders of the preferred stock may be entitled to distribution
and/or liquidation preferences. In either such case, we must pay the applicable distribution to the holders of our preferred stock before
we may pay distributions to the holders of our Common Stock.

 

    	 

    	 

    

 

No
Preemptive or Similar Rights

 

Our
stockholders have no preemptive, conversion or other rights to subscribe for additional shares of our Common Stock. 

 

Limitation
on Rights of Holders of Common Stock – Preferred Stock

 

The
rights, preferences and privileges of the holders of Common Stock are subject to, and may be adversely affected by, the rights of the
holders of shares of any series of preferred stock that we may designate in the future.

 

Our
Fourth Amended and Restated Certificate of Incorporation authorizes our Board of Directors, without further stockholder action, to provide
for the issuance of up to 20,000,000 shares of preferred stock. Our board of directors may, without further action by our stockholders,
fix the rights, preferences, privileges and restrictions of up to an aggregate of shares of preferred stock in one or more series and
authorize their issuance. These rights, preferences and privileges could include dividend rights, conversion rights, voting rights, terms
of redemption, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of such
series, any or all of which may be greater than the rights of our Common Stock. The issuance of our preferred stock could adversely affect
the voting power of holders of our Common Stock and the likelihood that such holders will receive dividend payments and payments upon
liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change of control
or other corporate action.

 

Certain
Anti-Takeover Matters

 

Fourth
Amended and Restated Certificate of Incorporation and Fifth Amended and Restated Bylaw Provisions

 

Our
Fourth Amended and Restated Certificate of Incorporation and Fifth Amended and Restated Bylaws contain certain provisions that are intended
to enhance the likelihood of continuity and stability in the composition of our board of directors and in the policies formulated by
our board of directors and to discourage an unsolicited takeover of our company if our board of directors determines that such a takeover
is not in the best interests of our company and stockholders. However, these provisions could have the effect of discouraging certain
attempts to acquire us or remove incumbent management even if some or a majority of our stockholders deemed such an attempt to be in
their best interests, including those attempts that might result in a premium over the market price for the shares of our Common Stock
held by stockholders.

 

Our
Fourth Amended and Restated Certificate of Incorporation and Fifth Amended and Restated Bylaws provide that our board of directors is
classified into three classes of directors. A third party may be discouraged from making a tender offer or otherwise attempting to obtain
control of us as it is more difficult and time consuming for stockholders to replace a majority of the directors on a classified board
of directors.

 

Our
Fifth Amended and Restated Bylaws establish advance notice procedures with regard to stockholder proposals and the nomination, other
than by or at the direction of the board of directors or a committee thereof, of candidates for election as directors. We may reject
a stockholder proposal or nomination that is not made in accordance with such procedures. In addition, our Fifth Amended and Restated
Bylaws provide that:

 

	 	●	special
                                                                              meetings of the stockholders of the Company may be called, for any purpose as is a proper matter for stockholder action under
                                                                              Delaware law, by only (i) the Chairperson of the board of directors, (ii) the Chief Executive Officer, or (iii) the Board of
                                                                              Directors;

	 	●	a
                                                                              director may not be removed from office without cause unless by the vote of the holders of 66 2/3% or more of the outstanding
                                                                              shares of our Common Stock entitled to vote at a special meeting of stockholders; and

	 	●	our
                                                                              Fifth Amended and Restated Bylaws may be altered, amended or repealed at any regular meeting of the stockholders (or at any
                                                                              special meeting thereof duly called for such purpose) by the affirmative vote of holders
                                                                              of at least 66 2/3% of our entire capital stock that is issued, outstanding and entitled to vote.

 

    	 

    	 

    

  

Section
203 of the Delaware General Corporation Law

 

We
are subject to the provisions of Section 203 of the DGCL. Under Section 203, we would generally be prohibited from engaging in any business
combination with any interested stockholder for a period of three years following the time that this stockholder became an interested
stockholder unless:

 

	 	●	prior
                                                         to this time, the board of directors of the corporation approved either the business combination or the transaction that
                                                         resulted in the stockholder becoming an interested stockholder;

	 	●	upon
consummation of the transaction that resulted in the stockholder’s becoming an interested stockholder, the interested stockholder
owned at least 85% of the voting stock of the corporation outstanding at the time the transaction commenced, excluding shares owned by
persons who are directors and also officers, and by employee stock plans in which employee participants do not have the right to determine
confidentially whether shares held subject to the plan will be tendered in a tender or exchange offer; or

	 	●	at
                                                                              or subsequent to such time, the business combination is approved by the board of directors and authorized at an annual or
                                                                              special meeting of stockholders, and not by written consent, by the affirmative vote of at least 66
                                                                              2⁄3% of the outstanding voting stock that is not owned by the interested stockholder.

 

Under
Section 203, a “business combination” includes:

 

	 	●	any
    merger or consolidation involving the corporation and the interested stockholder;
	 	●	any
                                                                              sale, transfer, pledge or other disposition of 10% or more of the assets of the corporation involving the interested
                                                                              stockholder;

	 	●	any
                                                                              transaction that results in the issuance or transfer by the corporation of any stock of the corporation to the interested
                                                                              stockholder, subject to limited exceptions;

	 	●	any
                                                                              transaction involving the corporation that has the effect of increasing the proportionate share of the stock of any class or series
                                                                              of the corporation beneficially owned by the interested stockholder; or

	 	●	the
                                                                              receipt by the interested stockholder of the benefit of any loans, advances, guarantees, pledges or other financial benefits
                                                                              provided by or through the corporation

 

In
general, Section 203 defines an interested stockholder as an entity or person beneficially owning 15% or more of the outstanding voting
stock of the corporation and any entity or person affiliated with or controlling or controlled by such entity or person.

 

Limitation
of Liability and Indemnification Matters

 

Article
VII of our Fourth Amended and Restated Certificate of Incorporation and Article 8 of our Fifth Amended and Restated Bylaws provide for
indemnification of our directors, officers, employees and other agents to the maximum extent permitted by applicable law. We also have
entered into indemnification agreements with our executive officers and directors and provide indemnity insurance pursuant to which directors
and officers are indemnified or insured against liability or loss under certain circumstances which may include liability or related
loss under the Securities Act and the Exchange Act.Exhibit 4.5

      DESCRIPTION OF SECURITIES

      

      

      The following description of Bullpen Parlay Acquisition Company’s (the “Company,” “we” or “us”) securities is a summary and does not purport to be complete. It is subject to and qualified in its entirety by reference
        to the Company’s amended and restated memorandum and articles of association, which is incorporated by reference as an exhibit to the Annual Report on Form 10-K of which this exhibit is a part. We encourage you to read the amended and restated
        memorandum and articles of association and the applicable provisions of the Companies Act (2021 Revision) of the Cayman Islands (the “Companies Act”), for additional information.

      

      

      General

      We are a Cayman Islands exempted company and our affairs are governed by our amended and restated memorandum and articles of association, the Companies Act and the common law of the Cayman Islands. Pursuant to our
        amended and restated memorandum and articles of association, we are authorized to issue 221,000,000 shares, $0.0001 par value each, including 200,000,000 Class A ordinary shares and 20,000,000 Class B ordinary shares, as well as 1,000,000
        preference shares, $0.0001 par value each. The following description summarizes the material terms of our shares as set out more particularly in our amended and restated memorandum and articles of association. Because it is only a summary, it may
        not contain all the information that is important to you.

      

      

      Units

      Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles its holder to purchase one Class A ordinary share at a price of
        $11.50 per share, subject to adjustment. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of the Company’s Class A ordinary shares. This means only a whole warrant may be exercised at any given
        time by a warrant holder. Holders will need to have their brokers contact our transfer agent in order to separate the units into Class A ordinary shares and warrants. Additionally, the units will automatically separate into their component parts
        and will not be traded after completion of our initial business combination.

      

      

      Ordinary Shares

      As of March 22, 2022, there were 28,750,000 ordinary shares outstanding, including:

      

      

      	

            	•	
              23,000,000 Class A ordinary shares underlying units issued as part of our initial public offering (the “IPO”); and

            

      	

            	•	
              5,750,000 Class B ordinary shares held by our initial shareholders

            

      

      

      Ordinary shareholders of record are entitled to one vote for each share held on all matters to be voted on by shareholders. Except as described below, holders of Class A ordinary shares and holders of Class B
        ordinary shares vote together as a single class on all matters submitted to a vote of our shareholders except as required by law or exchange rule. Unless specified in our amended and restated memorandum and articles of association, or as required
        by applicable provisions of the Companies Act or applicable stock exchange rules, an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the
        company, is required to approve any such matter voted on by our shareholders. Approval of certain actions will require a special resolution under Cayman Islands law, being the affirmative vote of at least two-thirds of our ordinary shares that are
        voted, and pursuant to our amended and restated memorandum and articles of association; such actions include amending our amended and restated memorandum and articles of association and approving a statutory merger or consolidation with another
        company.

      

      

       

      
        
          

      

      Our board of directors is divided into three classes, each of which will generally serve for a term of three years with only one class of directors being appointed in each year. There is no cumulative voting with
        respect to the appointment of directors, with the result that the holders of more than 50% of the shares voted for the appointment of directors can appoint all of the directors. However, only holders of Class B ordinary shares will have the right
        to appoint directors prior to or in connection with the completion of our initial business combination, meaning that holders of Class A ordinary shares will not have the right to appoint any directors until after the completion of our initial
        business combination. In addition, prior to the completion of an initial business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason. The provisions of our amended and restated
        memorandum and articles of association relating to the rights of holders of Class B ordinary shares to appoint or remove directors prior to our initial business combination may only be amended by a special resolution passed by a majority of at
        least 90% of our ordinary shares voting in a general meeting. Our shareholders are entitled to receive ratable dividends when, as and if declared by the board of directors out of funds legally available therefor.

      

      

      Because our amended and restated memorandum and articles of association authorize the issuance of up to 200,000,000 Class A ordinary shares, if we were to enter into a business combination, we may (depending on the
        terms of such a business combination) be required to increase the number of Class A ordinary shares which we are authorized to issue at the same time as our shareholders vote on the business combination to the extent we seek shareholder approval in
        connection with our initial business combination.

      

      

      Our board of directors is divided into three classes with only one class of directors being appointed in each year and each class (except for those directors appointed prior to our first annual general meeting)
        serving a three-year term. In accordance with Nasdaq corporate governance requirements, we are not required to hold an annual general meeting until one year after our first fiscal year end following our listing on Nasdaq. There is no requirement
        under the Companies Act for us to hold annual or extraordinary general meetings to appoint directors. We may not hold an annual general meeting to appoint new directors prior to the consummation of our initial business combination. Prior to the
        completion of an initial business combination, any vacancy on the board of directors may be filled by a nominee chosen by holders of a majority of our founder shares. In addition, prior to the completion of an initial business combination, holders
        of a majority of our founder shares may remove a member of the board of directors for any reason.

      

      

      We will provide our public shareholders with the opportunity to redeem all or a portion of their public shares upon the completion of our initial business combination at a per-share price, payable in cash, equal to
        the aggregate amount then on deposit in the trust account, calculated as of two business days prior to the consummation of our initial business combination, including interest (net of taxes paid or payable), divided by the number of then issued and
        outstanding public shares, subject to the limitations described herein. The amount in the trust account was initially $10.20 per public share. The per share amount we will distribute to investors who properly redeem their shares will not be reduced
        by the deferred underwriting commissions we will pay to the underwriter. Our initial shareholders have entered into agreements with us, pursuant to which they have agreed to waive their redemption rights with respect to their founder shares and
        public shares in connection with the completion of our initial business combination. The other members of our management team have entered into agreements similar to the one entered into by our sponsor with respect to any public shares acquired by
        them in or after our IPO.

      

      

      
        
          

      

      Unlike many blank check companies that hold shareholder votes and conduct proxy solicitations in conjunction with their initial business combinations and provide for related redemptions of public shares for cash upon
        completion of such initial business combinations even when a vote is not required by law, if a shareholder vote is not required by applicable law or stock exchange listing requirements and we do not decide to hold a shareholder vote for business or
        other reasons, we will, pursuant to our amended and restated memorandum and articles of association, conduct the redemptions pursuant to the tender offer rules of the SEC, and file tender offer documents with the SEC prior to completing our initial
        business combination. Our amended and restated memorandum and articles of association will require these tender offer documents to contain substantially the same financial and other information about the initial business combination and the
        redemption rights as is required under the SEC’s proxy rules. If, however, a shareholder approval of the transaction is required by applicable law or stock exchange listing requirements, or we decide to obtain shareholder approval for business or
        other reasons, we will, like many blank check companies, offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. If we seek shareholder approval, we will complete our
        initial business combination only if we receive an ordinary resolution under Cayman Islands law, which requires the affirmative vote of a majority of the shareholders who attend and vote at a general meeting of the company. However, the
        participation of our sponsor, officers, directors, advisors or their affiliates in privately negotiated transactions (if any, could result in the approval of our initial business combination even if a majority of our public shareholders vote, or
        indicate their intention to vote, against such initial business combination. For purposes of seeking approval of an ordinary resolution, non-votes and abstentions will have no effect on the approval of our initial business combination once a quorum
        is obtained. Our amended and restated memorandum and articles of association require that at least five days’ notice will be given of any general meeting. 

       

      

      If we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated
        memorandum and articles of association provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the
        Exchange Act), will be restricted from redeeming its shares with respect to Excess Shares, without our prior consent.

       

      

      However, we would not be restricting our shareholders’ ability to vote all of their shares (including Excess Shares) for or against our initial business combination. Our shareholders’ inability to redeem the Excess
        Shares will reduce their influence over our ability to complete our initial business combination, and such shareholders could suffer a material loss in their investment if they sell such Excess Shares on the open market. Additionally, such
        shareholders will not receive redemption distributions with respect to the Excess Shares if we complete our initial business combination. And, as a result, such shareholders will continue to hold that number of shares exceeding 15% and, in order to
        dispose such shares would be required to sell their shares in open market transactions, potentially at a loss.

       

      

      If we seek shareholder approval in connection with our initial business combination, our initial shareholders have agreed to vote their founder shares and any public shares purchased during or after the IPO in favor
        of our initial business combination. As a result, in addition to our initial shareholders, we would need 8,625,000, or 37.5% of the 23,000,000 public shares sold in our IPO to be voted in favor of a transaction, in order to have such initial
        business combination approved. The other members of our management team have entered into agreements similar to the one entered into by our sponsor with respect to any public shares acquired by them in or after the IPO. Additionally, each public
        shareholder may elect to redeem their public shares irrespective of whether they vote for or against the proposed transaction or vote at all.

       

      

      
        
          

      

       Pursuant to our amended and restated memorandum and articles of association, if we do not complete our initial business combination before June 7, 2023, we will (i) cease all operations except for the purpose of
        winding up; (ii) as promptly as reasonably possible but not more than 10 business days thereafter, redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including
        interest (less up to $100,000 of interest to pay dissolution expenses and net of taxes paid or payable), divided by the number of then outstanding public shares, which redemption will completely extinguish public shareholders’ rights as
        shareholders (including the right to receive further liquidation distributions, if any); and (iii) promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors,
        liquidate and dissolve, subject in each case, to our obligations under Cayman Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law. Our initial shareholders have entered into agreements
        with us, pursuant to which they have agreed to waive their rights to liquidating distributions from the trust account with respect to their founder shares if we fail to complete our initial business combination before June 7, 2023. However, our
        initial shareholders, management team who acquired public shares in or after our IPO will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to complete our initial business combination
        within the prescribed time period. Our amended and restated memorandum and articles of association provide that, if we wind up for any other reason prior to the consummation of our initial business combination, we will follow the foregoing
        procedures with respect to the liquidation of the trust account as promptly as reasonably possible but not more than 10 business days thereafter, subject to applicable Cayman Islands law. 

       

      

      In the event of a liquidation, dissolution or winding up of the company after a business combination, our shareholders are entitled to share ratably in all assets remaining available for distribution to them after
        payment of liabilities and after provision is made for each class of shares, if any, having preference over the ordinary shares. Our shareholders have no preemptive or other subscription rights. There are no sinking fund provisions applicable to
        the ordinary shares, except that we will provide our public shareholders with the opportunity to redeem their Class A ordinary shares for cash at a per share price equal to the aggregate amount then on deposit in the trust account, including
        interest (less up to $100,000 of interest to pay dissolution expenses and net of taxes paid or payable), divided by the number of then issued and outstanding public shares, upon the completion of our initial business combination, subject to the
        limitations described herein.

       

      

      Founder Shares

      

      

      The founder shares are designated as Class B ordinary shares and, except as described below, are identical to the Class A ordinary shares included in the units, and holders of founder shares have the same shareholder
        rights as public shareholders, except that (i) prior to our initial business combination, only holders of our Class B ordinary shares have the right to vote on the appointment of directors, including in connection with the completion of our initial
        business combination and holders of a majority of our Class B ordinary shares may remove a member of the board of directors for any reason; (ii) the founder shares are subject to certain transfer restrictions contained in a letter agreement that
        our initial shareholders, directors and officers have entered into with us, as described in more detail below; (iii) pursuant to such letter agreement, our initial shareholders, directors and officers have agreed to (A) waive their redemption
        rights with respect to their founder shares and public shares held by them, as applicable, in connection with the completion of our initial business combination, (B) waive their redemption rights with respect to their founder shares and public
        shares held by them, as applicable, in connection with a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (1) that would affect the substance or timing of our obligation to provide for the
        redemption of our public shares in connection with an initial business combination or to redeem 100% of our public shares if we have not consummated an initial business combination before June 7, 2023 or (2) with respect to any other provision
        relating to shareholders’ rights or pre-initial business combination activity (including extending the deadline for completing our initial business combination) and (C) waive their rights to liquidating distributions from the trust account with
        respect to their founder shares if we fail to complete our initial business combination before June 7, 2023 (although they will be entitled to liquidating distributions from the trust account with respect to any public shares they hold if we fail
        to complete our initial business combination within the prescribed time frame); (iv) the founder shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of our initial business
        combination, or earlier at the option of the holder thereof, as described below; and (v) the founder shares are entitled to registration rights. If we submit our initial business combination to our public shareholders for a vote, the anchor
        investors, our initial shareholders, directors and officers have agreed to vote their founder shares and any public shares purchased during or after our IPO in favor of our initial business combination. The other members of our management team have
        entered into agreements similar to the one entered into by our sponsor with respect to any public shares acquired by them in or after our IPO.

      

      

      
        
          

      

      The founder shares will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination, or earlier at the option of the holder
        thereof, on a one-for-one basis. However, if additional Class A ordinary shares or any other equity-linked securities are issued or deemed issued in excess of the amounts issued in our IPO and related to the closing of our initial business
        combination, the number of Class A ordinary shares issuable upon conversion of all founder shares will equal, in the aggregate, on an as converted basis, 20% of the sum of (i) the total number of ordinary shares outstanding plus (ii) the total
        number of Class A ordinary shares issued, or deemed issued or issuable upon conversion or exercise of any equity-linked securities or rights issued or deemed issued, by the company in connection with or in relation to the consummation of the
        initial business combination, excluding any Class A ordinary shares or equity-linked securities exercisable for or convertible into Class A ordinary shares issued, or to be issued, to any seller in the initial business combination and any private
        placement warrants issued to our sponsor upon conversion of working capital loans, provided that such conversion of Class B ordinary shares will never occur on a less than one-for-one basis.

      

      

      Our initial shareholders have agreed not to transfer, assign or sell any of their founder shares until the earlier to occur of: (i) one year after the completion of our initial business combination; and (ii)
        subsequent to our initial business combination (x) the date on which we complete a liquidation, merger, share exchange or other similar transaction that results in all of our shareholders having the right to exchange their Class A ordinary shares
        for cash, securities or other property or (y) if the closing price of our Class A ordinary shares equals or exceeds $12.00 per share (as adjusted for share sub-divisions, share capitalizations, reorganizations, recapitalizations and other similar
        transactions) for any 20 trading days within any 30-trading day period commencing at least 150 days after our initial business combination (except as described in the section entitled “Principal Shareholders — Transfers of Founder Shares and
        Private Placement Warrants”). Any permitted transferees will be subject to the same restrictions and other agreements of our initial shareholders with respect to any founder shares.

      

      

      Prior to our initial business combination, only holders of our founder shares will have the right to vote on the appointment of directors. Holders of our public shares will not be entitled to vote on the appointment
        of directors during such time. In addition, prior to the completion of an initial business combination, holders of a majority of our founder shares may remove a member of the board of directors for any reason. These provisions of our amended and
        restated memorandum and articles of association may only be amended by a special resolution passed by a majority of at least 90% of our ordinary shares voting in a general meeting. With respect to any other matter submitted to a vote of our
        shareholders, including any vote in connection with our initial business combination, except as required by law, holders of our founder shares and holders of our public shares will vote together as a single class, with each share entitling the
        holder to one vote.

      

      

      Register of Members

      

      

      Under Cayman Islands law, we must keep a register of members and there will be entered therein:

      

      

      
        
          

      

      	

            	•	
              the names and addresses of the members, a statement of the shares held by each member, and of the amount paid or agreed to be considered as paid, on the shares of each member and the voting rights of shares;

            

      	

            	•	
              the date on which the name of any person was entered on the register as a member; and

            

      	

            	•	
              the date on which any person ceased to be a member.

            

      

      

      Under Cayman Islands law, the register of members of our company is prima facie evidence of the matters set out therein (i.e., the register of members will raise a presumption of fact on the matters referred to above
        unless rebutted) and a member registered in the register of members will be deemed as a matter of Cayman Islands law to have legal title to the shares as set against its name in the register of members. However, there are certain limited
        circumstances where an application may be made to a Cayman Islands court for a determination on whether the register of members reflects the correct legal position. Further, the Cayman Islands court has the power to order that the register of
        members maintained by a company should be rectified where it considers that the register of members does not reflect the correct legal position. If an application for an order for rectification of the register of members were made in respect of our
        ordinary shares, then the validity of such shares may be subject to re-examination by a Cayman Islands court.

      

      

      Preference Shares

      Our amended and restated memorandum and articles of association authorize 1,000,000 preference shares and provide that preference shares may be issued from time to time in one or more series. Our board of directors
        will be authorized to fix the voting rights, if any, designations, powers, preferences, the relative, participating, optional or other special rights and any qualifications, limitations and restrictions thereof, applicable to the shares of each
        series. Our board of directors will be able to, without shareholder approval, issue preference shares with voting and other rights that could adversely affect the voting power and other rights of the holders of the ordinary shares and could have
        antitakeover effects. The ability of our board of directors to issue preference shares without shareholder approval could have the effect of delaying, deferring or preventing a change of control of us or the removal of existing management. We have
        no preference shares outstanding at the date hereof. Although we do not currently intend to issue any preference shares, we cannot assure you that we will not do so in the future.

      

      

      Warrants

      

      

      Public Shareholders’ Warrants

      Each whole warrant entitles the registered holder to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment as discussed below, at any time 30 days after the completion of our
        initial business combination, except as discussed in the immediately succeeding paragraph. Pursuant to the warrant agreement, a warrant holder may exercise its warrants only for a whole number of Class A ordinary shares. This means only a whole
        warrant may be exercised at a given time by a warrant holder. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Accordingly, unless you purchased a multiple of two units, the number of warrants
        issuable to you upon separation of the units will be rounded down to the nearest whole number of warrants. The warrants will expire five years after the completion of our initial business combination, at 5:00 p.m., New York City time, or earlier
        upon redemption or liquidation.

      

      

      We will not be obligated to deliver any Class A ordinary shares pursuant to the exercise of a warrant and will have no obligation to settle such warrant exercise unless a registration statement under the Securities
        Act with respect to the Class A ordinary shares underlying the warrants is then effective and a prospectus relating thereto is current, subject to our satisfying our obligations described below with respect to registration, or a valid exemption
        from registration is available. No warrant will be exercisable for cash or on a cashless basis, and we will not be obligated to issue a Class A ordinary share upon exercise of a warrant unless the Class A ordinary share issuable upon such warrant
        exercise has been registered, qualified or deemed to be exempt under the securities laws of the state of residence of the registered holder of the warrants. In the event that the conditions in the two immediately preceding sentences are not
        satisfied with respect to a warrant, the holder of such warrant will not be entitled to exercise such warrant and such warrant may have no value and expire worthless. In no event will we be required to net cash settle any warrant. In the event that
        a registration statement is not effective for the exercised warrants, the purchaser of a unit containing such warrant will have paid the full purchase price for the unit solely for the Class A ordinary share underlying such unit.

      

      

      
        
          

      

      We are not registering the Class A ordinary shares issuable upon exercise of the warrants at this time. However, we have agreed that as soon as practicable, but in no event
        later than 20 business days after the closing of our initial business combination, we will use our commercially reasonable efforts to file with the SEC a registration statement for the registration, under the Securities Act, of the Class A ordinary
        shares issuable upon exercise of the warrants, and we will use our commercially reasonable efforts to cause the registration statement to become effective within 60 business days after the closing of our initial business combination, and to
        maintain the effectiveness of such registration statement and a current prospectus relating to those Class A ordinary shares until the warrants expire or are redeemed, as specified in the warrant agreement; provided that if our Class A ordinary
        shares are at the time of any exercise of a warrant not listed on a national securities exchange such that they satisfy the definition of a “covered security” under Section 18(b) (1) of the Securities Act, we may, at our option, require holders of
        public warrants who exercise their warrants to do so on a  “cashless basis” in accordance with Section 3(a)(9) of the Securities Act and, in the event we so elect, we will not be required to file or maintain in effect a registration statement, but
        we will use our commercially reasonable efforts to register or qualify the shares under applicable blue sky laws to the extent an exemption is not available. If a registration statement covering the Class A ordinary shares issuable upon exercise of
        the warrants is not effective by the 60th business day after the closing of the initial business combination, warrant holders may, until such time as there is an effective registration statement and during any period when we will have
        failed to maintain an effective registration statement, exercise warrants on a “cashless basis” in accordance with Section 3(a)(9) of the Securities Act or another exemption, but we will use our commercially reasonable efforts to register or
        qualify the shares under applicable blue sky laws to the extent an exemption is not available. In such event, each holder would pay the exercise price by surrendering the warrants for that number of Class A ordinary shares equal to the lesser of
        (A) the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants, multiplied by the excess of the “Fair Market Value” (defined below) less the exercise price of the warrants by (y) the Fair
        Market Value and (B) 0.361. The “Fair Market Value” as used in this paragraph shall mean the volume weighted average price of the Class A ordinary shares for the 10 trading days ending on the trading day prior to the date on which the notice of
        exercise is received by the warrant agent. 

       

      

      Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00.

      Once the warrants become exercisable, we may redeem the outstanding warrants (except as described herein with respect to the private placement warrants): 

       

      

      
        	 	
                •

              	
                in whole and not in part; •

              

      

      
        	 	
                •

              	
                at a price of $0.01 per warrant; •

              

      

      
        	 	
                •

              	
                upon a minimum of 30 days’ prior written notice of redemption to each warrant holder; and

              

      

      
        	 	
                •

              	
                if, and only if, the closing price of the Class A ordinary shares equals or exceeds $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the
                  heading “— Warrants — Public Shareholders’ Warrants — Anti-dilution Adjustments”) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to the
                  warrant holders.

              

         

        

        
          
            

        

         We will not redeem the warrants as described above unless a registration statement under the Securities Act covering the issuance of the Class A ordinary shares issuable upon exercise of the warrants is then
          effective and a current prospectus relating to those Class A ordinary shares is available throughout the 30-day redemption period. We may exercise our redemption right even if we are unable to register or qualify the underlying securities for
          sale under all applicable state securities laws. As a result, we may redeem warrants even if the holders are otherwise unable to exercise their warrants.

         

        

        We have established the $18.00 (as adjusted) redemption criterion discussed above to prevent a redemption call unless there is at the time of the call a significant premium
          to the warrant exercise price. If the foregoing conditions are satisfied and we issue a notice of redemption of the warrants, each warrant holder will be entitled to exercise his, her or its warrant prior to the scheduled redemption date.
          However, the price of the Class A ordinary shares may fall below the $18.00 redemption trigger price (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “—
          Warrants — Public Shareholders’ Warrants — Anti-dilution Adjustments”) as well as the $11.50 (for whole shares) warrant exercise price after the redemption notice is issued.

         

        

        Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00.

        Once the warrants become exercisable, we may redeem the outstanding warrants:

         

        

        
          	 	
                  •

                	
                  in whole and not in part;

                

        

        
          	 	
                  •

                	
                  at $0.10 per warrant upon a minimum of 30 days’ prior written notice of redemption provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares determined by
                    reference to the table below, based on the redemption date and the “Fair Market Value” of our Class A ordinary shares (as defined below) except as otherwise described below ;

                

        

        
          	 	
                  •

                	
                  if, and only if, the closing price of Class A ordinary shares equals or exceeds $10.00 per public share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under
                    the heading “— Warrants — Public Shareholders’ Warrants — Anti-dilution Adjustments”) for any 20 trading days within the 30-trading day period ending three trading days before we send the notice of redemption to the warrant holders; and

                

        

        
          	 	
                  •

                	
                  if the closing price of the Class A ordinary shares for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to
                    the warrant holders is less than $18.00 per share (as adjusted for adjustments to the number of shares issuable upon exercise or the exercise price of a warrant as described under the heading “— Warrants — Public Shareholders’ Warrants
                    — Anti-dilution Adjustments”), the private placement warrants must also be concurrently called for redemption on the same terms as the outstanding public warrants, as described above.

                

           

          

        

        Beginning on the date the notice of redemption is given until the warrants are redeemed or exercised, holders may elect to exercise their warrants on a cashless basis. The numbers in the table below represent the
          number of Class A ordinary shares that a warrant holder will receive upon such cashless exercise in connection with a redemption by us pursuant to this redemption feature, based on the “Fair Market Value” of our Class A ordinary shares on the
          corresponding redemption date (assuming holders elect to exercise their warrants and such warrants are not redeemed for $0.10 per warrant), determined for these purposes based on volume weighted average price of our Class A ordinary shares during
          the 10 trading days immediately following the date on which the notice of redemption is sent to the holders of warrants, and the number of months that the corresponding redemption date precedes the expiration date of the warrants, each as set
          forth in the table below. We will provide our warrant holders with the final Fair Market Value no later than one business day after the 10-trading day period described above ends.

         

        

      

      
        
          

      

      Pursuant to the warrant agreement, references above to Class A ordinary shares shall include a security other than Class A ordinary shares into which the Class A ordinary shares have been converted or exchanged for
        in the event we are not the surviving company in our initial business combination. The numbers in the table below will not be adjusted when determining the number of Class A ordinary shares to be issued upon exercise of the warrants if we are not
        the surviving entity following our initial business combination.

       

      

      The share prices set forth in the column headings of the table below will be adjusted as of any date on which the number of shares issuable upon exercise of a warrant or the exercise price of a warrant is adjusted as
        set forth under the heading “— Anti-dilution Adjustments” below. If the number of shares issuable upon exercise of a warrant is adjusted, the adjusted share prices in the column headings will equal the share prices immediately prior to such
        adjustment, multiplied by a fraction, the numerator of which is the number of shares deliverable upon exercise of a warrant immediately prior to such adjustment and the denominator of which is the number of shares deliverable upon exercise of a
        warrant as so adjusted. The number of shares in the table below shall be adjusted in the same manner and at the same time as the number of shares issuable upon exercise of a warrant. If the exercise price of a warrant is adjusted, (a) in the case
        of an adjustment pursuant to the fifth paragraph under the heading “— Anti-dilution Adjustments” below, the adjusted share prices in the column headings will equal the unadjusted share price multiplied by a fraction, the numerator of which is the
        higher of the Market Value and the Newly Issued Price as set forth under the heading “— Anti-dilution Adjustments” and the denominator of which is $10.00 and (b) in the case of an adjustment pursuant to the second paragraph under the heading “—
        Anti-dilution Adjustments” below, the adjusted share prices in the column headings will equal the unadjusted share price less the decrease in the exercise price of a warrant pursuant to such exercise price adjustment.

       

      

      
        	 	 	
                
                  Fair Market Value of Class A Ordinary Shares

                

              	 
	
                
                  Redemption Date

                  (period to expiration of warrants)

                

              	 	
                
                  ≤10.00

                

              	 	 	 	
                
                  11.00

                

              	 	 	 	
                
                  12.00

                

              	 	 	 	
                
                  13.00

                

              	 	 	 	
                
                  14.00

                

              	 	 	 	
                
                  15.00

                

              	 	 	 	
                
                  16.00

                

              	 	 	 	
                
                  17.00

                

              	 	 	
                
                  ≥18.00

                

              	 
	
                60 months

              	 	 	
                0.261

              	 	 	 	
                0.281

              	 	 	 	
                0.297

              	 	 	 	
                0.311

              	 	 	 	
                0.324

              	 	 	 	
                0.337

              	 	 	 	
                0.348

              	 	 	 	
                0.358

              	 	 	 	
                0.361

              	 
	
                57 months

              	 	 	
                0.257

              	 	 	 	
                0.277

              	 	 	 	
                0.294

              	 	 	 	
                0.310

              	 	 	 	
                0.324

              	 	 	 	
                0.337

              	 	 	 	
                0.348

              	 	 	 	
                0.358

              	 	 	 	
                0.361

              	 
	
                54 months

              	 	 	
                0.252

              	 	 	 	
                0.272

              	 	 	 	
                0.291

              	 	 	 	
                0.307

              	 	 	 	
                0.322

              	 	 	 	
                0.335

              	 	 	 	
                0.347

              	 	 	 	
                0.357

              	 	 	 	
                0.361

              	 
	
                51 months

              	 	 	
                0.246

              	 	 	 	
                0.268

              	 	 	 	
                0.287

              	 	 	 	
                0.304

              	 	 	 	
                0.320

              	 	 	 	
                0.333

              	 	 	 	
                0.346

              	 	 	 	
                0.357

              	 	 	 	
                0.361

              	 
	
                48 months

              	 	 	
                0.241

              	 	 	 	
                0.263

              	 	 	 	
                0.283

              	 	 	 	
                0.301

              	 	 	 	
                0.317

              	 	 	 	
                0.332

              	 	 	 	
                0.344

              	 	 	 	
                0.356

              	 	 	 	
                0.361

              	 
	
                45 months

              	 	 	
                0.235

              	 	 	 	
                0.258

              	 	 	 	
                0.279

              	 	 	 	
                0.298

              	 	 	 	
                0.315

              	 	 	 	
                0.330

              	 	 	 	
                0.343

              	 	 	 	
                0.356

              	 	 	 	
                0.361

              	 
	
                42 months

              	 	 	
                0.228

              	 	 	 	
                0.252

              	 	 	 	
                0.274

              	 	 	 	
                0.294

              	 	 	 	
                0.312

              	 	 	 	
                0.328

              	 	 	 	
                0.342

              	 	 	 	
                0.355

              	 	 	 	
                0.361

              	 
	
                39 months

              	 	 	
                0.221

              	 	 	 	
                0.246

              	 	 	 	
                0.269

              	 	 	 	
                0.290

              	 	 	 	
                0.309

              	 	 	 	
                0.325

              	 	 	 	
                0.340

              	 	 	 	
                0.354

              	 	 	 	
                0.361

              	 
	
                36 months

              	 	 	
                0.213

              	 	 	 	
                0.239

              	 	 	 	
                0.263

              	 	 	 	
                0.285

              	 	 	 	
                0.305

              	 	 	 	
                0.323

              	 	 	 	
                0.339

              	 	 	 	
                0.353

              	 	 	 	
                0.361

              	 
	
                33 months

              	 	 	
                0.205

              	 	 	 	
                0.232

              	 	 	 	
                0.257

              	 	 	 	
                0.280

              	 	 	 	
                0.301

              	 	 	 	
                0.320

              	 	 	 	
                0.337

              	 	 	 	
                0.352

              	 	 	 	
                0.361

              	 
	
                30 months

              	 	 	
                0.196

              	 	 	 	
                0.224

              	 	 	 	
                0.250

              	 	 	 	
                0.274

              	 	 	 	
                0.297

              	 	 	 	
                0.316

              	 	 	 	
                0.335

              	 	 	 	
                0.351

              	 	 	 	
                0.361

              	 
	
                27 months

              	 	 	
                0.185

              	 	 	 	
                0.214

              	 	 	 	
                0.242

              	 	 	 	
                0.268

              	 	 	 	
                0.291

              	 	 	 	
                0.313

              	 	 	 	
                0.332

              	 	 	 	
                0.350

              	 	 	 	
                0.361

              	 
	
                24 months

              	 	 	
                0.173

              	 	 	 	
                0.204

              	 	 	 	
                0.233

              	 	 	 	
                0.260

              	 	 	 	
                0.285

              	 	 	 	
                0.308

              	 	 	 	
                0.329

              	 	 	 	
                0.348

              	 	 	 	
                0.361

              	 
	
                21 months

              	 	 	
                0.161

              	 	 	 	
                0.193

              	 	 	 	
                0.223

              	 	 	 	
                0.252

              	 	 	 	
                0.279

              	 	 	 	
                0.304

              	 	 	 	
                0.326

              	 	 	 	
                0.347

              	 	 	 	
                0.361

              	 
	
                18 months

              	 	 	
                0.146

              	 	 	 	
                0.179

              	 	 	 	
                0.211

              	 	 	 	
                0.242

              	 	 	 	
                0.271

              	 	 	 	
                0.298

              	 	 	 	
                0.322

              	 	 	 	
                0.345

              	 	 	 	
                0.361

              	 
	
                15 months

              	 	 	
                0.130

              	 	 	 	
                0.164

              	 	 	 	
                0.197

              	 	 	 	
                0.230

              	 	 	 	
                0.262

              	 	 	 	
                0.291

              	 	 	 	
                0.317

              	 	 	 	
                0.342

              	 	 	 	
                0.361

              	 
	
                12 months

              	 	 	
                0.111

              	 	 	 	
                0.146

              	 	 	 	
                0.181

              	 	 	 	
                0.216

              	 	 	 	
                0.250

              	 	 	 	
                0.282

              	 	 	 	
                0.312

              	 	 	 	
                0.339

              	 	 	 	
                0.361

              	 
	
                9 months

              	 	 	
                0.090

              	 	 	 	
                0.125

              	 	 	 	
                0.162

              	 	 	 	
                0.199

              	 	 	 	
                0.237

              	 	 	 	
                0.272

              	 	 	 	
                0.305

              	 	 	 	
                0.336

              	 	 	 	
                0.361

              	 
	
                6 months

              	 	 	
                0.065

              	 	 	 	
                0.099

              	 	 	 	
                0.137

              	 	 	 	
                0.178

              	 	 	 	
                0.219

              	 	 	 	
                0.259

              	 	 	 	
                0.296

              	 	 	 	
                0.331

              	 	 	 	
                0.361

              	 
	
                3 months

              	 	 	
                0.034

              	 	 	 	
                0.065

              	 	 	 	
                0.104

              	 	 	 	
                0.150

              	 	 	 	
                0.197

              	 	 	 	
                0.243

              	 	 	 	
                0.286

              	 	 	 	
                0.326

              	 	 	 	
                0.361

              	 
	
                0 months

              	 	 	
                —

              	 	 	 	
                —

              	 	 	 	
                0.042

              	 	 	 	
                0.115

              	 	 	 	
                0.179

              	 	 	 	
                0.233

              	 	 	 	
                0.281

              	 	 	 	
                0.323

              	 	 	 	
                0.361

              	 

      

       

      

      
        
          

      

      The exact fair market value and redemption date may not be set forth in the table above, in which case, if the fair market value is between two values in the table or the redemption date is between two redemption
        dates in the table, the number of Class A ordinary shares to be issued for each warrant exercised will be determined by a straight-line interpolation between the number of shares set forth for the higher and lower fair market values and the earlier
        and later redemption dates, as applicable, based on a 365 or 366-day year, as applicable. For example, if the volume weighted average price of our Class A ordinary shares during the 10 trading days immediately following the date on which the notice
        of redemption is sent to the holders of the warrants is $11.00 per share, and at such time there are 57 months until the expiration of the warrants, holders may choose to, in connection with this redemption feature, exercise their warrants for
        0.277 Class A ordinary shares for each whole warrant. For an example where the exact fair market value and redemption date are not as set forth in the table above, if the volume weighted average price of our Class A ordinary shares during the 10
        trading days immediately following the date on which the notice of redemption is sent to the holders of the warrants is $13.50 per share, and at such time there are 38 months until the expiration of the warrants, holders may choose to, in
        connection with this redemption feature, exercise their warrants for 0.298 Class A ordinary shares for each whole warrant. In no event will the warrants be exercisable on a cashless basis in connection with this redemption feature for more than
        0.361 Class A ordinary shares per warrant (subject to adjustment). Finally, as reflected in the table above, if the warrants are out of the money and about to expire, they cannot be exercised on a cashless basis in connection with a redemption by
        us pursuant to this redemption feature, since they will not be exercisable for any Class A ordinary shares.

      

      

      This redemption feature differs from the warrant redemption features used in some other blank check offerings, which typically only provide for a redemption of warrants for cash (other than the private placement
        warrants) when the trading price for the Class A ordinary shares exceeds $18.00 per share for a specified period of time. This redemption feature is structured to allow for all of the outstanding warrants to be redeemed when the Class A ordinary
        shares are trading at or above $10.00 per public share, which may be at a time when the trading price of our Class A ordinary shares is below the exercise price of the warrants. We have established this redemption feature to provide us with the
        flexibility to redeem the warrants without the warrants having to reach the $18.00 per share threshold set forth above under“—  Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00.”Holders choosing to exercise
        their warrants in connection with a redemption pursuant to this feature will, in effect, receive a number of shares for their warrants based on an option pricing model with a fixed volatility input. This redemption right provides us with an
        additional mechanism by which to redeem all of the outstanding warrants, and therefore have certainty as to our capital structure as the warrants would no longer be outstanding and would have been exercised or redeemed. We will be required to pay
        the applicable redemption price to warrant holders if we choose to exercise this redemption right and it will allow us to quickly proceed with a redemption of the warrants if we determine it is in our best interest to do so. As such, we would
        redeem the warrants in this manner when we believe it is in our best interest to update our capital structure to remove the warrants and pay the redemption price to the warrant holders.

      

      

      As stated above, we can redeem the warrants when the Class A ordinary shares are trading at a price starting at $10.00, which is below the exercise price of $11.50, because it will provide certainty with respect to
        our capital structure and cash position while providing warrant holders with the opportunity to exercise their warrants on a cashless basis for the applicable number of shares. If we choose to redeem the warrants when the Class A ordinary shares
        are trading at a price below the exercise price of the warrants, this could result in the warrant holders receiving fewer Class A ordinary shares than they would have received if they had chosen to wait to exercise their warrants for Class A
        ordinary shares if and when such Class A ordinary shares were trading at a price higher than the exercise price of $11.50.

      

      

      No fractional Class A ordinary shares will be issued upon exercise. If, upon exercise, a holder would be entitled to receive a fractional interest in a share, we will round down to the nearest whole number of the
        number of Class A ordinary shares to be issued to the holder. If, at the time of redemption, the warrants are exercisable for a security other than the Class A ordinary shares pursuant to the warrant agreement (for instance, if we are not the
        surviving company in our initial business combination), the warrants may be exercised for such security. At such time as the warrants become exercisable for a security other than the Class A ordinary shares, the Company (or surviving company) will
        use its commercially reasonable efforts to register under the Securities Act the security issuable upon the exercise of the warrants.

      

      

      
        
          

      

      Redemption Procedures. A holder of a warrant may notify us in writing in the event it elects to be subject to a
        requirement that such holder will not have the right to exercise such warrant, to the extent that after giving effect to such exercise, such person (together with such person’s affiliates), to the warrant agent’s actual knowledge, would
        beneficially own in excess of 9.8% (or such other amount as a holder may specify) of the Class A ordinary shares issued and outstanding immediately after giving effect to such exercise.

      

      

      Anti-Dilution Adjustments. If the number of issued and outstanding Class A ordinary shares is increased by a
        capitalization or share dividend paid in Class A ordinary shares to all or substantially all holders of Class A ordinary shares, or by a split-up of Class A ordinary shares or other similar event, then, on the effective date of such capitalization
        or share dividend, split-up or similar event, the number of Class A ordinary shares issuable on exercise of each warrant will be increased in proportion to such increase in the issued and outstanding Class A ordinary shares. A rights offering made
        to all or substantially all holders of ordinary shares entitling holders to purchase Class A ordinary shares at a price less than the “historical fair market value” (as defined below) will be deemed a share dividend of a number of Class A ordinary
        shares equal to the product of (i) the number of Class A ordinary shares actually sold in such rights offering (or issuable under any other equity securities sold in such rights offering that are convertible into or exercisable for Class A ordinary
        shares) and (ii) one minus the quotient of (x) the price per Class A ordinary share paid in such rights offering and (y) the historical fair market value. For these purposes, (i) if the rights offering is for securities convertible into or
        exercisable for Class A ordinary shares, in determining the price payable for Class A ordinary shares, there will be taken into account any consideration received for such rights, as well as any additional amount payable upon exercise or conversion
        and (ii) “historical fair market value” means the volume weighted average price of Class A ordinary shares as reported during the 10 trading day period ending on the trading day prior to the first date on which the Class A ordinary shares trade on
        the applicable exchange or in the applicable market, regular way, without the right to receive such rights.

      

      

      In addition, if we, at any time while the warrants are outstanding and unexpired, pay a dividend or make a distribution in cash, securities or other assets to all or substantially all of the holders of Class A
        ordinary shares on account of such Class A ordinary shares (or other securities into which the warrants are then convertible), other than (a) as described above, (b) any cash dividends or cash distributions which, when combined on a per share basis
        with all other cash dividends and cash distributions paid on the Class A ordinary shares during the 365-day period ending on the date of declaration of such dividend or distribution, does not exceed $0.50 (as adjusted to appropriately reflect any
        other adjustments and excluding cash dividends or cash distributions that resulted in an adjustment to the exercise price or to the number of Class A ordinary shares issuable on exercise of each warrant) but only with respect to the amount of the
        aggregate cash dividends or cash distributions equal to or less than $0.50 per share, (c) to satisfy the redemption rights of the holders of Class A ordinary shares in connection with a proposed initial business combination, (d) to satisfy the
        redemption rights of the holders of Class A ordinary shares in connection with a shareholder vote to approve an amendment to our amended and restated memorandum and articles of association (i) that would affect the substance or timing of our
        obligation to provide for the redemption of our public shares in connection with an initial business combination or to redeem 100% of our public shares if we have not consummated an initial business combination before June 7, 2023 or (ii) with
        respect to any other provision relating to shareholders’rights or pre-initial business combination activity, or (e) in connection with the redemption of our public shares upon our failure
        to complete our initial business combination, then the warrant exercise price will be decreased, effective immediately after the effective date of such event, by the amount of cash and/or the fair market value of any securities or other assets paid
        on each Class A ordinary share in respect of such event. If the number of issued and outstanding Class A ordinary shares is decreased by a consolidation, combination, reverse share split or reclassification of Class A ordinary shares or other
        similar event, then, on the effective date of such consolidation, combination, reverse share split, reclassification or similar event, the number of Class A ordinary shares issuable on exercise of each warrant will be decreased in proportion to
        such decrease in issued and outstanding Class A ordinary shares.

      

      

      
        
          

      

      Whenever the number of Class A ordinary shares purchasable upon the exercise of the warrants is adjusted, as described above, the warrant exercise price will be adjusted by multiplying the warrant exercise price
        immediately prior to such adjustment by a fraction (x) the numerator of which will be the number of Class A ordinary shares purchasable upon the exercise of the warrants immediately prior to such adjustment and (y) the denominator of which will be
        the number of Class A ordinary shares so purchasable immediately thereafter. In addition, if (x) we issue additional ordinary shares or equity-linked securities for capital raising purposes in connection with the closing of our initial business
        combination at an issue price or effective issue price of less than $9.20 per ordinary share (with such issue price or effective issue price to be determined in good faith by our board of directors and, in the case of any such issuance to our
        sponsor or its affiliates, without taking into account any founder shares held by our sponsor or such affiliates, as applicable, prior to such issuance) (the “Newly Issued Price”), (y) the aggregate gross proceeds from such issuances represent more
        than 60% of the total equity proceeds, and interest thereon, available for the funding of our initial business combination on the date of the completion of our initial business combination (net of redemptions), and (z) the volume weighted average
        trading price of our Class A ordinary shares during the 20 trading day period starting on the trading day prior to the day on which we consummate our initial business combination (such price, the “Market Value”) is below $9.20 per share, then the
        exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the higher of the Market Value and the Newly Issued Price, the $10.00 per share redemption trigger price described above under “— Redemption of warrants
        when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal to the higher of the Market Value and the Newly Issued Price, and the $18.00 per share redemption trigger price described above
        under “— Redemption of warrants when the price per Class A ordinary share equals or exceeds $18.00” and “— Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00” will be adjusted (to the nearest cent) to be equal
        to 180% of the higher of the Market Value and the Newly Issued Price.

      

      

      In case of any reclassification or reorganization of the issued and outstanding Class A ordinary shares (other than those described above or that solely affects the par value of such Class A ordinary shares), or in
        the case of any merger or consolidation of us with or into another corporation (other than a consolidation or merger in which we are the continuing corporation and that does not result in any reclassification or reorganization of our issued and
        outstanding Class A ordinary shares), or in the case of any sale or conveyance to another corporation or entity of the assets or other property of us as an entirety or substantially as an entirety in connection with which we are dissolved, the
        holders of the warrants will thereafter have the right to purchase and receive, upon the basis and upon the terms and conditions specified in the warrants and in lieu of the Class A ordinary shares immediately theretofore purchasable and receivable
        upon the exercise of the rights represented thereby, the kind and amount of Class A ordinary shares or other securities or property (including cash) receivable upon such reclassification, reorganization, merger or consolidation, or upon a
        dissolution following any such sale or transfer, that the holder of the warrants would have received if such holder had exercised their warrants immediately prior to such event. However, if such holders were entitled to exercise a right of election
        as to the kind or amount of securities, cash or other assets receivable upon such consolidation or merger, then the kind and amount of securities, cash or other assets for which each warrant will become exercisable will be deemed to be the weighted
        average of the kind and amount received per share by such holders in such consolidation or merger that affirmatively make such election, and if a tender, exchange or redemption offer has been made to and accepted by such holders (other than a
        tender, exchange or redemption offer made by the company in connection with redemption rights held by shareholders of the company as provided for in the company’s amended and restated memorandum and articles of association or as a result of the
        redemption of Class A ordinary shares by the company if a proposed initial business combination is presented to the shareholders of the company for approval) under circumstances in which, upon completion of such tender or exchange offer, the maker
        thereof, together with members of any group (within the meaning of Rule 13d-5(b)(1) under the Exchange Act) of which such maker is a part, and together with any affiliate or associate of such maker (within the meaning of Rule 12b-2 under the
        Exchange Act) and any members of any such group of which any such affiliate or associate is a part, own beneficially (within the meaning of Rule 13d-3 under the Exchange Act) more than 50% of the issued and outstanding Class A ordinary shares, the
        holder of a warrant will be entitled to receive the highest amount of cash, securities or other property to which such holder would actually have been entitled as a shareholder if such warrant holder had exercised the warrant prior to the
        expiration of such tender or exchange offer, accepted such offer and all of the Class A ordinary shares held by such holder had been purchased pursuant to such tender or exchange offer, subject to adjustment (from and after the consummation of such
        tender or exchange offer) as nearly equivalent as possible to the adjustments provided for in the warrant agreement. If less than 70% of the consideration receivable by the holders of Class A ordinary shares in such a transaction is payable in the
        form of Class A ordinary shares in the successor entity that is listed for trading on a national securities exchange or is quoted in an established over-the-counter market, or is to be so listed for trading or quoted immediately following such
        event, and if the registered holder of the warrant properly exercises the warrant within thirty days following public disclosure of such transaction, the warrant exercise price will be reduced as specified in the warrant agreement based on the
        Black- Scholes value (as defined in the warrant agreement) of the warrant. The purpose of such exercise price reduction is to provide additional value to holders of the warrants when an extraordinary transaction occurs during the exercise period of
        the warrants pursuant to which the holders of the warrants otherwise do not receive the full potential value of the warrants.

      

      

      
        
          

      

      The warrants will be issued in registered form under a warrant agreement between U.S. Bank, as warrant agent, and us. The warrant agreement provides that the terms of the warrants may be amended without the consent
        of any holder for the purpose of (i) curing any ambiguity or correct any mistake, including to conform the provisions of the warrant agreement to the description of the terms of the warrants and the warrant agreement set forth in the prospectus
        filed in connection with our IPO, or defective provision (ii) amending the provisions relating to cash dividends on ordinary shares as contemplated by and in accordance with the warrant agreement or (iii) adding or changing any provisions with
        respect to matters or questions arising under the warrant agreement as the parties to the warrant agreement may deem necessary or desirable and that the parties deem to not adversely affect the rights of the registered holders of the warrants,
        provided that the approval by the holders of at least 50% of the then outstanding public warrants is required to make any change that adversely affects the interests of the registered holders and, solely with respect to any amendment to the terms
        of the private placement warrants or any provision of the warrant agreement with respect to the private placement warrants, at least 50% of the then outstanding private placement warrants.

      

      

      The warrant holders do not have the rights or privileges of holders of ordinary shares and any voting rights until they exercise their warrants and receive Class A ordinary shares. After the issuance of Class A
        ordinary shares upon exercise of the warrants, each holder will be entitled to one vote for each share held of record on all matters to be voted on by shareholders. No fractional warrants will be issued upon separation of the units and only whole
        warrants will trade. If, upon exercise of the warrants, a holder would be entitled to receive a fractional interest in a share, we will, upon exercise, round down to the nearest whole number the number of Class A ordinary shares to be issued to the
        warrant holder. We have agreed that, subject to applicable law, any action, proceeding or claim against us arising out of or relating in any way to the warrant agreement will be brought and enforced in the courts of the State of New York or the
        United States District Court for the Southern District of New York, and we irrevocably submit to such jurisdiction, which jurisdiction will be the exclusive forum for any such action, proceeding or claim. See “Risk Factors — Our warrant agreement
        designates the courts of the State of New York or the United States District Court for the Southern District of New York as the sole and exclusive forum for certain types of actions and proceedings that may be initiated by holders of our warrants,
        which could limit the ability of warrant holders to obtain a favorable judicial forum for disputes with our company” in our prospectus. This provision applies to claims under the Securities Act but does not apply to claims under the Exchange Act or
        any claim for which the federal district courts of the United States of America are the sole and exclusive forum.

      

      

      
        
          

      

      Private Placement Warrants

      

      

      Except as described below, the private placement warrants have terms and provisions that are identical to those of the warrants sold as part of the units in our IPO. The private placement warrants (including the
        Class A ordinary shares issuable upon exercise of the private placement warrants) will not be transferable, assignable or salable until 30 days after the completion of our initial business combination (except pursuant to limited exceptions as
        described under “Principal Shareholders — Transfers of Founder Shares and Private Placement Warrants,” to our officers and directors and other persons or entities affiliated with the initial purchasers of the private placement warrants) and they
        will not be redeemable by us (except as described under “— Warrants — Public Shareholders’ Warrants — Redemption of warrants when the price per Class A ordinary share equals or exceeds $10.00”) so long as they are held by our sponsor or its
        permitted transferees (except as otherwise set forth herein). Our sponsor, or its permitted transferees, have the option to exercise the private placement warrants on a cashless basis. If the private placement warrants are held by holders other
        than our sponsor, or its permitted transferees, the private placement warrants will be redeemable by us in all redemption scenarios and exercisable by the holders on the same basis as the warrants included in the units being sold in our IPO. Any
        amendment to the terms of the private placement warrants or any provision of the warrant agreement with respect to the private placement warrants will require a vote of holders of at least 50% of the number of the then outstanding private placement
        warrants. In connection with a redemption of our warrants when the price per Class A ordinary share equals or exceeds $10.00, holders of private placement warrants who exercise their shares on a cashless basis would receive that number of shares
        determined by reference to the table set forth under “— Warrants — Public Shareholders’ Warrants.” If holders of private placement warrants elect to exercise them on a cashless basis at any time other than in connection with such a redemption of
        warrants by us, they would pay the exercise price by surrendering their warrants for that number of Class A ordinary shares equal to the quotient obtained by dividing (x) the product of the number of Class A ordinary shares underlying the warrants,
        multiplied by the excess of the “Sponsor Fair Market Value” (defined below) over the exercise price of the warrants by (y) the Sponsor Fair Market Value. The “Sponsor Fair Market Value” shall mean the average reported closing price of the Class A
        ordinary shares for the 10 trading days ending on the third trading day prior to the date on which the notice of warrant exercise is sent to the warrant agent. We expect to have policies in place that restrict insiders from selling our securities
        except during specific periods. Even during such periods of time when insiders will be permitted to sell our securities, an insider cannot trade in our securities if he or she is in possession of material non-public information. Accordingly, unlike
        public shareholders who could exercise their warrants and sell the Class A ordinary shares received upon such exercise freely in the open market in order to recoup the cost of such exercise, the insiders could be significantly restricted from
        selling such securities. As a result, we believe that allowing the holders to exercise such warrants on a cashless basis is appropriate.

      

      

      In order to fund working capital deficiencies or finance transaction costs in connection with an intended initial business combination, our sponsor or an affiliate of our sponsor or certain of our officers and
        directors may, but are not obligated to, loan us funds as may be required. Up to $1,500,000 of such loans may be convertible into warrants of the post business combination entity at a price of $1.00 per warrant at the option of the lender. Such
        warrants would be identical to the private placement warrants.

      

      

      
        
          

      

      Dividends

      

      

      We have not paid any cash dividends on our ordinary shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash dividends in the future will
        be dependent upon our revenues and earnings, if any, capital requirements and general financial condition subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination
        will be within the discretion of our board of directors at such time. We effected a share capitalization or with respect to our Class B ordinary shares on December 6, 2021, in such amount as to maintain the number of founder shares, on an
        as-converted basis, at 20% of the total number of Class A ordinary shares and Class B ordinary shares. Further, if we incur any indebtedness in connection with our initial business combination, our ability to declare dividends may be limited by
        restrictive covenants we may agree to in connection therewith.

      

      

      Our Transfer Agent and Warrant Agent

      

      

      The transfer agent for our ordinary shares and warrant agent for our warrants is American Stock Transfer & Trust Company, LLC. We have agreed to indemnify American Stock Transfer & Trust Company, LLC in its
        roles as transfer agent and warrant agent, its agents and each of its shareholders, directors, officers and employees against all claims and losses that may arise out of acts performed or omitted for its activities in that capacity, except for any
        claims and losses due to any gross negligence or intentional misconduct of the indemnified person or entity. American Stock Transfer & Trust Company, LLC has agreed that it has no right of set-off or any right, title, interest or claim of any
        kind to, or to any monies in, the trust account, and has irrevocably waived any right, title, interest or claim of any kind to, or to any monies in, the trust account that it may have now or in the future. Accordingly, any indemnification provided
        will only be able to be satisfied, or a claim will only be able to be pursued, solely against us and our assets outside the trust account and not against the any monies in the trust account or interest earned thereon.

      

      

      Certain Differences in Corporate Law

      

      

      Cayman Islands companies are governed by the Companies Act. The Companies Act is modeled on English Law but does not follow recent English Law statutory enactments, and differs from laws applicable to U.S.
        corporations and their shareholders. Set forth below is a summary of the material differences between the provisions of the Companies Act applicable to us and the laws applicable to companies incorporated in the United States and their
        shareholders.

      

      

      Mergers and Similar Arrangements. In certain circumstances, the Companies Act allows for mergers or consolidations between two Cayman Islands companies, or between a Cayman Islands exempted company and a company
        incorporated in another jurisdiction (provided that is facilitated by the laws of that other jurisdiction).

      

      

      
        
          

      

      Where the merger or consolidation is between two Cayman Islands companies, the directors of each company must approve a written plan of merger or consolidation containing certain prescribed information. That plan or
        merger or consolidation must then be authorized by (a) a special resolution (usually a majority of 66-2∕3% in value of the voting shares voted at a general meeting) of the shareholders of each company and (b) such other authorization, if any, as
        may be specified in such constituent company’s articles of association. No shareholder resolution is required for a merger between a parent company (i.e., a company that owns at least 90% of the issued shares of each class in a subsidiary company)
        and its subsidiary company. The consent of each holder of a fixed or floating security interest of a constituent company must be obtained, unless the court waives such requirement. If the Cayman Islands Registrar of Companies is satisfied that the
        requirements of the Companies Act (which includes certain other formalities) have been complied with, the Registrar of Companies will register the plan of merger or consolidation. Where the merger or consolidation involves a foreign company, the
        procedure is similar, save that with respect to the foreign company, the directors of the Cayman Islands exempted company are required to make a declaration to the effect that, having made due enquiry, they are of the opinion that the requirements
        set out below have been met: (i) that the merger or consolidation is permitted or not prohibited by the constitutional documents of the foreign company and by the laws of the jurisdiction in which the foreign company is incorporated, and that those
        laws and any requirements of those constitutional documents have been or will be complied with; (ii) that no petition or other similar proceeding has been filed and remains outstanding or order made or resolution adopted to wind up or liquidate the
        foreign company in any jurisdictions; (iii) that no receiver, trustee, administrator or other similar person has been appointed in any jurisdiction and is acting in respect of the foreign company, its affairs or its property or any part thereof;
        and (iv) that no scheme, order, compromise or other similar arrangement has been entered into or made in any jurisdiction whereby the rights of creditors of the foreign company are and continue to be suspended or restricted. Where the surviving
        company is the Cayman Islands exempted company, the directors of the Cayman Islands exempted company are further required to make a declaration to the effect that, having made due enquiry, they are of the opinion that the requirements set out below
        have been met: (i) that the foreign company is able to pay its debts as they fall due and that the merger or consolidated is bona fide and not intended to defraud unsecured creditors of the foreign company; (ii) that in respect of the transfer of
        any security interest granted by the foreign company to the surviving or consolidated company (a) consent or approval to the transfer has been obtained, released or waived, (b) the transfer is permitted by and has been approved in accordance with
        the constitutional documents of the foreign company, and (c) the laws of the jurisdiction of the foreign company with respect to the transfer have been or will be complied with; (iii) that the foreign company will, upon the merger or consolidation
        becoming effective, cease to be incorporated, registered or exist under the laws of the relevant foreign jurisdiction; and (iv) that there is no other reason why it would be against the public interest to permit the merger or consolidation.

      

      

      Where the above procedures are adopted, the Companies Act provides for a right of dissenting shareholders to be paid a payment of the fair value of his shares upon their dissenting to the merger or consolidation if
        they follow a prescribed procedure. In essence, that procedure is as follows: (a) the shareholder must give his written objection to the merger or consolidation to the constituent company before the vote on the merger or consolidation, including a
        statement that the shareholder proposes to demand payment for his shares if the merger or consolidation is authorized by the vote; (b) within 20 days following the date on which the merger or consolidation is approved by the shareholders, the
        constituent company must give written notice to each shareholder who made a written objection; (c) a shareholder must within 20 days following receipt of such notice from the constituent company, give the constituent company a written notice of his
        intention to dissent including, among other details, a demand for payment of the fair value of his shares; (d) within seven days following the date of the expiration of the period set out in paragraph (b) above or seven days following the date on
        which the plan of merger or consolidation is filed, whichever is later, the constituent company, the surviving company or the consolidated company must make a written offer to each dissenting shareholder to purchase his shares at a price that the
        company determines is the fair value and if the company and the shareholder agree the price within 30 days following the date on which the offer was made, the company must pay the shareholder such amount; and (e) if the company and the shareholder
        fail to agree a price within such 30-day period, within 20 days following the date on which such 30-day period expires, the company (and any dissenting shareholder) must file a petition with the Cayman Islands Grand Court to determine the fair
        value and such petition must be accompanied by a list of the names and addresses of the dissenting shareholders with whom agreements as to the fair value of their shares have not been reached by the company. At the hearing of that petition, the
        court has the power to determine the fair value of the shares together with a fair rate of interest, if any, to be paid by the company upon the amount determined to be the fair value. Any dissenting shareholder whose name appears on the list filed
        by the company may participate fully in all proceedings until the determination of fair value is reached. These rights of a dissenting shareholder are not available in certain circumstances, for example, to dissenters holding shares of any class in
        respect of which an open market exists on a recognized stock exchange or recognized interdealer quotation system at the relevant date or where the consideration for such shares to be contributed are shares of any company listed on a national
        securities exchange or shares of the surviving or consolidated company.

      

      

      
        
          

      

      Moreover, Cayman Islands law has separate statutory provisions that facilitate the reconstruction or amalgamation of companies in certain circumstances, schemes of arrangement will generally be more suited for
        complex mergers or other transactions involving widely held companies, commonly referred to in the Cayman Islands as a “scheme of arrangement” which may be tantamount to a merger. In the event that a merger was sought pursuant to a scheme of
        arrangement (the procedures for which are more rigorous and take longer to complete than the procedures typically required to consummate a merger in the United States), the arrangement in question must be approved by a majority in number of each
        class of shareholders and creditors with whom the arrangement is to be made and who must in addition represent three-fourths in value of each such class of shareholders or creditors, as the case may be, that are present and voting either in person
        or by proxy at a meeting, or meeting summoned for that purpose. The convening of the meetings and subsequently the terms of the arrangement must be sanctioned by the Grand Court of the Cayman Islands. While a dissenting shareholder would have the
        right to express to the court the view that the transaction should not be approved, the court can be expected to approve the arrangement if it satisfies itself that:

      	

            	•	
              we are not proposing to act illegally or beyond the scope of our corporate authority and the statutory provisions as to majority vote have been complied with ;

            

      	

            	•	
              the shareholders have been fairly represented at the meeting in question;

            

      	

            	•	
              the arrangement is such as a businessman would reasonably approve; and

            

      	

            	•	
              the arrangement is not one that would more properly be sanctioned under some other provision of the Companies Act or that would amount to a “fraud on the minority.”

            

      If a scheme of arrangement or takeover offer (as described below) is approved, any dissenting shareholder would have no rights comparable to appraisal rights (providing rights to receive payment in cash for the
        judicially determined value of the shares), which would otherwise ordinarily be available to dissenting shareholders of U.S. corporations.

      

      

      Squeeze-out Provisions.

      When a takeover offer is made and accepted by holders of 90% of the shares to whom the offer is made within four months, the offer or may, within a two-month period, require the holders of the remaining shares to
        transfer such shares on the terms of the offer. An objection can be made to the Grand Court of the Cayman Islands, but this is unlikely to succeed unless there is evidence of fraud, bad faith, collusion or inequitable treatment of the shareholders.

      

      

      Further, transactions similar to a merger, reconstruction and/or an amalgamation may in some circumstances be achieved through means other than these statutory provisions, such as a share capital exchange, asset
        acquisition or control, or through contractual arrangements of an operating business.

      

      

      Shareholders’ Suits. Maples and Calder (Cayman) LLP, our Cayman Islands counsel, is not aware of any reported class action having been brought in a Cayman
        Islands court. Derivative actions have been brought in the Cayman Islands courts, and the Cayman Islands courts have confirmed the availability for such actions. In most cases, we will be the proper plaintiff in any claim based on a breach of duty
        owed to us, and a claim against (for example) our officers or directors usually may not be brought by a shareholder. However, based both on Cayman Islands authorities and on English authorities, which would in all likelihood be of persuasive
        authority and be applied by a court in the Cayman Islands, exceptions to the foregoing principle apply in circumstances in which:

      	

            	•	
              a company is acting, or proposing to act, illegally or beyond the scope of its authority;

            

      	

            	•	
              the act complained of, although not beyond the scope of the authority, could be effected if duly authorized by more than the number of votes which have actually been obtained; or

            

      	

            	•	
              those who control the company are perpetrating a “fraud on the minority.”

            

      

      

      A shareholder may have a direct right of action against us where the individual rights of that shareholder have been infringed or are about to be infringed.

      

      

      
        
          

      

      Enforcement of Civil Liabilities. The Cayman Islands has a different body of securities laws as compared to the United States and provides less protection
        to investors. Additionally, Cayman Islands companies may not have standing to sue before the Federal courts of the United States.

      

      

      We have been advised by Maples and Calder (Cayman) LLP, our Cayman Islands legal counsel, that the courts of the Cayman Islands are unlikely (i) to recognize or enforce against us judgments of courts of the United
        States predicated upon the civil liability provisions of the federal securities laws of the United States or any state, and (ii) in original actions brought in the Cayman Islands, to impose liabilities against us predicated upon the civil liability
        provisions of the federal securities laws of the United States or any state, so far as the liabilities imposed by those provisions are penal in nature. In those circumstances, although there is no statutory enforcement in the Cayman Islands of
        judgments obtained in the United States, the courts of the Cayman Islands will recognize and enforce a foreign money judgment of a foreign court of competent jurisdiction without retrial on the merits based on the principle that a judgment of a
        competent foreign court imposes upon the judgment debtor an obligation to pay the sum for which judgment has been given provided certain conditions are met. For a foreign judgment to be enforced in the Cayman Islands, such judgment must be final
        and conclusive and for a liquidated sum, and must not be in respect of taxes or a fine or penalty, inconsistent with a Cayman Islands judgment in respect of the same matter, impeachable on the grounds of fraud or obtained in a manner, and or be of
        a kind the enforcement of which is, contrary to natural justice or the public policy of the Cayman Islands (awards of punitive or multiple damages may well be held to be contrary to public policy). A Cayman Islands Court may stay enforcement
        proceedings if concurrent proceedings are being brought elsewhere.

      

      

      Special Considerations for Exempted Companies. We are an exempted company with limited liability under the Companies Act. The Companies Act distinguishes
        between ordinary resident companies and exempted companies. Any company that is registered in the Cayman Islands but conducts business mainly outside of the Cayman Islands may apply to be registered as an exempted company. The requirements for an
        exempted company are essentially the same as for an ordinary company except for the exemptions and privileges listed below:

      	

            	•	
              annual reporting requirements are minimal and consist mainly of a statement that the company has conducted its operations mainly outside of the Cayman Islands and has complied with the provisions of the Companies Act;

            

      	

            	•	
              an exempted company’s register of members is not open to inspection;

            

      	

            	•	
              an exempted company does not have to hold an annual general meeting;

            

      	

            	•	
              an exempted company may issue shares with no par value;

            

      	

            	•	
              an exempted company may obtain an undertaking against the imposition of any future taxation (such undertakings are usually given for 20 years in the first instance);

            

      	

            	•	
              an exempted company may register by way of continuation in another jurisdiction and be deregistered in the Cayman Islands;

            

      	

            	•	
              an exempted company may register as a limited duration company; and

            

      	

            	•	
              an exempted company may register as a segregated portfolio company.

            

      

      

      “Limited liability” means that the liability of each shareholder is limited to the amount unpaid by the shareholder on the shares of the company (except in exceptional circumstances, such as involving fraud, the
        establishment of an agency relationship or an illegal or improper purpose or other circumstances in which a court may be prepared to pierce or lift the corporate veil).

      

      

      
        
          

      

      Amended and Restated Memorandum and Articles of Association

      

      

      Our amended and restated memorandum and articles of association contain provisions designed to provide certain rights and protections relating to our IPO that will apply to us until the completion of our initial
        business combination. These provisions cannot be amended without a special resolution. As a matter of Cayman Islands law, a resolution is deemed to be a special resolution under Cayman Islands law where it has been approved by either (i) the
        affirmative vote of at least two-thirds (or any higher threshold specified in a company’s articles of association) of a company’s shareholders entitled to vote and so voting at a general meeting for which notice specifying the intention to propose
        the resolution as a special resolution has been given, or (ii) if so authorized by a company’s articles of association, by a unanimous written resolution of all of the company’s shareholders. Our amended and restated memorandum and articles of
        association provide that special resolutions must be approved either by at least two thirds of our shareholders (i.e., the lowest threshold permissible under Cayman Islands law), or by a unanimous written resolution of all of our shareholders.

      

      

      Our initial shareholders, who collectively beneficially own 20% of our ordinary shares, will participate in any vote to amend our amended and restated memorandum and articles of association and will have the
        discretion to vote in any manner they choose. Specifically, our amended and restated memorandum and articles of association provide, among other things, that:

      	

            	•	
              If we do not complete our initial business combination before June 7, 2023, we will (i) cease all operations except for the purpose of winding up; (ii) as promptly as reasonably possible but not more than 10 business days thereafter,
                redeem the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (less up to $100,000 of interest to pay dissolution expenses and net of taxes paid or
                payable), divided by the number of then issued and outstanding public shares, which redemption will completely extinguish public shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if
                any); and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining shareholders and our board of directors, liquidate and dissolve, subject in each case, to our obligations under Cayman
                Islands law to provide for claims of creditors and in all cases subject to the other requirements of applicable law;

            

      	

            	•	
              Prior to our initial business combination, we may not issue additional shares that would entitle the holders thereof to (i) receive funds from the trust account or (ii) vote as a class with our public shares (a) on any initial business
                combination or (b) to approve an amendment to our amended and restated memorandum and articles of association to extend the time we have to consummate a business combination beyond June 7, 2023;

            

      	

            	•	
              In the event we seek to complete our initial business combination with a company that is affiliated with our sponsor or any of our founders, officers or directors, we, or a committee of independent directors, will obtain an opinion from
                an independent investment banking firm that is a member of FINRA or an independent accounting firm that such initial business combination or transaction is fair to our company from a financial point of view;

            

      	

            	•	
              If a shareholder vote on our initial business combination is not required by applicable law or stock exchange listing requirements and we do not decide to hold a shareholder vote for business or other reasons, we will offer to redeem our
                public shares pursuant to Rule 13e-4 and Regulation 14E of the Exchange Act, and will file tender offer documents with the SEC prior to completing our initial business combination which contain substantially the same financial and other
                information about our initial business combination and the redemption rights as is required under Regulation 14A of the Exchange Act;

            

      	

            	•	
              We must consummate an initial business combination with one or more operating businesses or assets with a fair market value equal to at least 80% of the net assets held in the trust account (net of amounts disbursed to management for
                working capital purposes and excluding the amount of any deferred underwriting discount held in trust) at the time of our signing a definitive agreement in connection with our initial business combination;

            

      
        
          

      

      	

            	•	
              If our shareholders approve an amendment to our amended and restated memorandum and articles of association (i) that would affect the substance or timing of our obligation to provide for the redemption of our public shares in connection
                with an initial business combination or to redeem 100% of our public shares if we have not consummated an initial business combination before June 7, 2023 or (ii) with respect to any other provision relating to shareholders’ rights or
                pre-initial business combination activity, we will provide our public shareholders with the opportunity to redeem all or a portion of their public shares upon such approval at a per-share price, payable in cash, equal to the aggregate
                amount then on deposit in the trust account, including interest (net of taxes paid or payable) divided by the number of then issued and outstanding public shares, subject to the limitations described herein; and

            

      	

            	•	
              We will not effectuate our initial business combination solely with another blank check company or a similar company with nominal operations.

            

      In addition, our amended and restated memorandum and articles of association provide that under no circumstances will we redeem our public shares in an amount that would cause our net tangible assets to be less than
        $5,000,001 upon completion of our initial business combination.

      

      

      The Companies Act permits a company incorporated in the Cayman Islands to amend its memorandum and articles of association with the approval of a special resolution which requires the approval of the holders of at
        least two-thirds of such company’s issued and outstanding ordinary shares who attend and vote at a general meeting or by way of unanimous written resolution. A company’s articles of association may specify that the approval of a higher majority is
        required but, provided the approval of the required majority is obtained, any Cayman Islands exempted company may amend its memorandum and articles of association regardless of whether its memorandum and articles of association provides otherwise.
        Accordingly, although we could amend any of the provisions relating to our structure and business plan which are contained in our amended and restated memorandum and articles of association, we view all of these provisions as binding obligations to
        our shareholders and neither we, nor our officers or directors, will take any action to amend or waive any of these provisions unless we provide dissenting public shareholders with the opportunity to redeem their public shares.

      

      

      Anti-Money Laundering - Cayman Islands

      

      

      If any person in the Cayman Islands knows or suspects, or has reasonable grounds for knowing or suspecting, that another person is engaged in criminal conduct or money laundering or is involved with terrorism or
        terrorist financing and property and the information for that knowledge or suspicion came to their attention in the course of business in the regulated sector or other trade, profession, business or employment, the person will be required to report
        such knowledge or suspicion to (i) the Financial Reporting Authority of the Cayman Islands, pursuant to the Proceeds of Crime Law (As Revised) of the Cayman Islands if the disclosure relates to criminal conduct or money laundering or (ii) a police
        officer of the rank of constable or higher, or the Financial Reporting Authority, pursuant to the Terrorism Law (As Revised) of the Cayman Islands, if the disclosure relates to involvement with terrorism or terrorist financing and property. Such a
        report will not be treated as a breach of confidence or of any restriction upon the disclosure of information imposed by any enactment or otherwise.

      

      

      Cayman Islands Data Protection

      

      

      We have certain duties under the Data Protection Act (As Revised) of the Cayman Islands (the “DPA”) based on internationally accepted principles of data privacy.

      

      

      Privacy Notice

      

      

      Introduction

      

      

      This privacy notice puts our shareholders on notice that through your investment in the company you will provide us with certain personal information which constitutes personal data within the meaning of the DPA
        (“personal data”). In the following discussion, the “Company” refers to us and our affiliates and/or delegates, except where the context requires otherwise.

      

      

      
        
          

      

      Investor Data

      

      

      We will collect, use, disclose, retain and secure personal data to the extent reasonably required only and within the parameters that could be reasonably expected during the normal course of business. We will only
        process, disclose, transfer or retain personal data to the extent legitimately required to conduct our activities of on an ongoing basis or to comply with legal and regulatory obligations to which we are subject. We will only transfer personal data
        in accordance with the requirements of the DPA, and will apply appropriate technical and organizational information security measures designed to protect against unauthorized or unlawful processing of the personal data and against the accidental
        loss, destruction or damage to the personal data. In our use of this personal data, we will be characterized as a “data controller” for the purposes of the DPA, while our affiliates and service providers who may receive this personal data from us
        in the conduct of our activities may either act as our “data processors” for the purposes of the DPA or may process personal information for their own lawful purposes in connection with services provided to us. We may also obtain personal data from
        other public sources. Personal data includes, without limitation, the following information relating to a shareholder and/or any individuals connected with a shareholder as an investor: name, residential address, email address, contact details,
        corporate contact information, signature, nationality, place of birth, date of birth, tax identification, credit history, correspondence records, passport number, bank account details, source of funds details and details relating to the
        shareholder’s investment activity.

      

      

      Who This Affects

      

      

      If you are a natural person, this will affect you directly. If you are a corporate investor (including, for these purposes, legal arrangements such as trusts or exempted limited partnerships) that provides us with
        personal data on individuals connected to you for any reason in relation your investment in the company, this will be relevant for those individuals and you should transmit the content of this Privacy Notice to such individuals or otherwise advise
        them of its content.

      

      

      How the Company May Use a Shareholder’s Personal Data

      

      

      The company, as the data controller, may collect, store and use personal data for lawful purposes, including, in particular:

      

      

      (i)       where this is necessary for the performance of our rights and obligations under any purchase agreements;

      (ii)      where this is necessary for compliance with a legal and regulatory obligation to which we are subject (such as compliance with anti-money laundering and FATCA/CRS
        requirements); and/or

      (iii)     where this is necessary for the purposes of our legitimate interests and such interests are not overridden by your interests, fundamental rights or freedoms.

      

      

      Should we wish to use personal data for other specific purposes (including, if applicable, any purpose that requires your consent), we will contact you.

      

      

      Why We May Transfer Your Personal Data

      

      

      
        
          

      

      In certain circumstances we may be legally obliged to share personal data and other information with respect to your shareholding with the relevant regulatory authorities such as the Cayman Islands Monetary Authority
        or the Tax Information Authority. They, in turn, may exchange this information with foreign authorities, including tax authorities. We anticipate disclosing personal data to persons who provide services to us and their respective affiliates (which
        may include certain entities located outside the United States, the Cayman Islands or the European Economic Area), who will process your personal data on our behalf.

      

      

      The Data Protection Measures We Take

      

      

      Any transfer of personal data by us or our duly authorized affiliates and/or delegates outside of the Cayman Islands shall be in accordance with the requirements of the DPA. We and our duly authorized affiliates
        and/or delegates shall apply appropriate technical and organizational information security measures designed to protect against unauthorized or unlawful processing of personal data, and against accidental loss or destruction of, or damage to,
        personal data. We shall notify you of any personal data breach that is reasonably likely to result in a risk to your interests, fundamental rights or freedoms or those data subjects to whom the relevant personal data relates.

      

      

      Certain Anti-Takeover Provisions of Our Amended and Restated Memorandum and Articles of Association

      

      

      Our amended and restated memorandum and articles of association provide that our board of directors be classified into three classes of directors and also include provisions providing for advance notice procedures,
        inability of shareholders to call a general meeting and removal of directors only for cause and only by the board of directors. As a result, in most circumstances, a person can gain control of our board only by successfully engaging in a proxy
        contest at two or more annual general meetings. In addition, prior to our initial business combination, only holders of our Class B ordinary shares have the right to vote on the appointment of directors, including in connection with the completion
        of our initial business combination and holders of a majority of our Class B ordinary shares may remove a member of the board of directors for any reason. These provisions of our amended and restated memorandum and articles of association relating
        to the rights of holders of Class B ordinary shares to appoint or remove directors prior to our initial business combination may only be amended by a special resolution which shall include the affirmative vote of a majority of our Class B ordinary
        shares. Our authorized but unissued Class A ordinary shares and preference shares are available for future issuances without shareholder approval and could be utilized for a variety of corporate purposes, including future offerings to raise
        additional capital, acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved Class A ordinary shares and preference shares could render more difficult or discourage an attempt to obtain control of us by means
        of a proxy contest, tender offer, merger or otherwise.

      

      

      Securities Eligible for Future Sale

      

      

      We have 28,750,000 ordinary shares issued and outstanding. Of these shares, the 23,000,000 Class A ordinary shares sold in our IPO are freely tradable without restriction or further registration under the Securities
        Act, except for any Class A ordinary shares purchased by one of our affiliates within the meaning of Rule 144 under the Securities Act. All of the 5,750,000 founder shares outstanding founder shares and all of the 11,700,000 are restricted
        securities under Rule 144, in that they were issued in private transactions not involving a public offering.

      

      

      
        
          

      

      Rule 144

      

      

      Pursuant to Rule 144, a person who has beneficially owned restricted shares or warrants for at least six months would be entitled to sell their securities provided that (i) such person is not deemed to have been one
        of our affiliates at the time of, or at any time during the three months preceding, a sale and (ii) we are subject to the Exchange Act periodic reporting requirements for at least three months before the sale and have filed all required reports
        under Section 13 or 15(d) of the Exchange Act during the 12 months (or such shorter period as we were required to file reports) preceding the sale.

      

      

      Persons who have beneficially owned restricted shares or warrants for at least six months but who are our affiliates at the time of, or at any time during the three months preceding, a sale, would be subject to
        additional restrictions, by which such person would be entitled to sell within any three-month period only a number of securities that does not exceed the greater of:

      	

            	•	
              1% of the total number of ordinary shares then issued and outstanding, which will equal 287,500 shares; or

            

      	

            	•	
              the average weekly reported trading volume of the Class A ordinary shares during the four calendar weeks preceding the filing of a notice on Form 144 with respect to the sale.

            

      

      

      Sales by our affiliates under Rule 144 are also limited by manner of sale provisions and notice requirements and to the availability of current public information about us.

      

      

      Restrictions on the Use of Rule 144 by Shell Companies or Former Shell Companies

      

      

      Rule 144 is not available for the resale of securities initially issued by shell companies (other than business combination related shell companies) or issuers that have been at any time previously a shell company.
        However, Rule 144 also includes an important exception to this prohibition if the following conditions are met:

      	

            	•	
              the issuer of the securities that was formerly a shell company has ceased to be a shell company;

            

      	

            	•	
              the issuer of the securities is subject to the reporting requirements of Section 13 or 15(d) of the Exchange Act;

            

      	

            	•	
              the issuer of the securities has filed all Exchange Act reports and material required to be filed, as applicable, during the preceding 12 months (or such shorter period that the issuer was required to file such reports and materials),
                other than Form 8-K reports; and

            

      	

            	•	
              at least one year has elapsed from the time that the issuer filed current Form 10 type information with the SEC reflecting its status as an entity that is not a shell company.

            

      As a result, our initial shareholders will be able to sell their founder shares and private placement warrants, as applicable, pursuant to Rule 144 without registration one year after we have completed our initial
        business combination.

      

      

      Registration Rights

      The holders of the founder shares, private placement warrants and warrants that may be issued upon conversion of working capital loans (and any Class A ordinary shares issuable upon the exercise of the private
        placement warrants and warrants that may be issued upon conversion of working capital loans) are entitled to registration rights pursuant to a registration rights agreement. The holders of these securities are entitled to make up to three demands,
        excluding short form demands, that we register such securities. In addition, the holders have certain “piggy-back” registration rights with respect to registration statements filed subsequent to our completion of our initial business combination.
        We will bear the expenses incurred in connection with the filing of any such registration statements.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00342-of-00352.parquet"}]]